Fundraising Fox

Supira Medical

Campbell, US · Delaware corporation · 140 employees on LinkedIn · 7 known investors

Find your way into Supira Medical

355 people in our graph share verified history with the Supira Medical team — schools, employers, funds. One of them is your warm intro.

Amanda Hersonunlockedknows Nitin Salunke · together at The Wharton School (overlapped)
×9knows the team · via University of Oklahoma
knows the team · via COEP Technological University
knows the team · via University of Maryland Baltimore County

Supira Medical develops a next-generation percutaneous ventricular assist device (pVAD) to provide temporary mechanical circulatory support for high-risk patients undergoing coronary interventions and those in cardiogenic shock. It is a cardiovascular medical device company formed by the Shifamed innovation hub.

HardwareHealthtechMedical Devices

Founders & leadership

NSNitin Salunke
Nitin SalunkeinPresident & CEO; Member of the Board of DirectorsNitin Salunke is a medical device executive with three decades of experience in development and leadership of Class II and III cardiovascular and neurovascular products across technical, clinical, operations, and general management roles. His background spans cardiology, structural heart, endovascular, and mechanical circulatory support device domains.
JO
Jean OrthNamed on SEC filing
MMMariam Maghribi
Mariam MaghribiNamed on SEC filing

Board

CG
Casey GordonBoard director
CS
Christopher ShenBoard director
BC
Bihua ChenBoard director
ASAmr Salahieh
Amr SalahiehBoard director

Investors · 7

415 Capital✓ verifiedMunich · $5.4M – $16.2M
Amed Ventures✓ verifiedLewes
The Capital Partnership✓ verifiedLondon
Novo Holdingsreported · 2 sourcesCopenhagen · $1.1M – $54M
Unorthodox VenturesreportedAustin · $1M – $5M

Also in the syndicate · 2

Cormorant Asset ManagementThe Capital Partnership (TCP)

Reported raises · per SEC filings

Form D private placements

$220.7M disclosed across 6 rounds · 2017–2025

▶$120MraisedApr 2025 · 20 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Nitin SalunkeExecutive Officer, Director
  • Casey GordonDirector
  • Christopher ShenDirector
  • Amr SalahiehDirector
  • Bihua ChenDirector
Offering amount
$120M
Amount sold
$120M
First sale
Mar 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$21.1MraisedDec 2023 · 22 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Nitin SalunkeExecutive Officer, Director
  • Bihua ChenDirector
  • Amr SalahiehDirector
  • Casey GordonDirector
Offering amount
$40M
Amount sold
$21.1M
First sale
Nov 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$30MraisedMar 2022 · 31 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Nitin SalunkeExecutive Officer, Director
  • Casey GordonDirector
  • Amr SalahiehDirector
  • Bihua ChenDirector
Offering amount
$30M
Amount sold
$30M
First sale
Feb 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$35.1MraisedMar 2020 · 31 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Amr SalahiehDirector
  • Casey GordonDirector
  • Bihua ChenDirector
  • Nitin SalunkeExecutive Officer, Director
Offering amount
$35.1M
Amount sold
$35.1M
First sale
Feb 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$12.9MraisedMay 2018 · 24 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Amr SalahiehDirector
  • Casey GordonDirector
  • Mariam MaghribiExecutive Officer
  • Jean OrthExecutive Officer, Director
Offering amount
$12.9M
Amount sold
$12.9M
First sale
Apr 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.6MraisedDec 2017 · 15 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Amr SalahiehDirector
  • Jean OrthExecutive Officer
  • Mariam MaghribiExecutive Officer, Director
Offering amount
$2M
Amount sold
$1.6M
First sale
Dec 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 6

by search overlap
Aviary Health11 shared keywordsAviary Health provides virtual and hybrid clinical programs — including cardiac rehabilitation, pulmonary rehabilitation, and chronic care management — combining AI-powered workflows with clinical teams. It serves hospitals and health systems, delivering end-to-end support for complex service lines.
Rf Surgical10 shared keywordsMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Insightra Medical10 shared keywordsInsightra Medical develops intra-aortic balloon pump (IABP) catheters used to temporarily support heart function, including a 7Fr IAB catheter kit compatible with Arrow and Datascope consoles. The products are FDA-cleared medical devices intended for use by medical professionals in cardiac catheterization settings.
Bioworld9 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Syncardia7 shared keywordsSynCardia manufactures the world's first commercially approved total artificial heart for patients with end-stage heart failure awaiting transplant. The company develops and delivers mechanical circulatory support devices as alternatives to heart transplantation for critically ill patients.
Topera7 shared keywordsAbbott's Lingo Glucose System is a continuous glucose monitoring device for non-insulin users aged 18+, designed to track glucose levels and support metabolic health decisions.

Companies competing with Supira Medical for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Supira Medical Raises $120M to Propel Innovative Heart Device Market Expansion - Third Newsthird-news.com · Mar 2025Supira Medical Raises $120M in Series E Financingfinsmes.com · Mar 2025Supira Medical Secures $120M Oversubscribed Series E Financing and Completes Enrollment of SUPPORT I Early Feasibility Study in the United States - Supira Medicalsupiramedical.com · Mar 2025Supira Medical, Inc., a Shifamed Portfolio Company, Receives FDA Breakthrough Device Designation as the Company Closed $40M in Series D Financing - Supira Medicalsupiramedical.com · Nov 2023Supira Medical Funding Round Will Support Development of Its Percutaneous Ventricular Assist Device - Cardiac Interventions Todaycitoday.com · Feb 2022Supira Medical, a Shifamed Portfolio Company, Closes $30M in an Oversubscribed Series C Financing - Medtech Alertmedtechalert.com · Feb 2022

Frequently asked questions

What does Supira Medical do?
Supira Medical develops a next-generation percutaneous ventricular assist device (pVAD) to provide temporary mechanical circulatory support for high-risk patients undergoing coronary interventions and those in cardiogenic shock. It is a cardiovascular medical device company formed by the Shifamed innovation hub.
Who are Supira Medical's investors?
Supira Medical's investors include 415 Capital, Amed Ventures, The Capital Partnership, Novo Holdings, Unorthodox Ventures.
How much funding has Supira Medical raised?
Supira Medical has disclosed $220.7M raised across 6 rounds.
Where is Supira Medical headquartered?
Supira Medical is headquartered in Campbell, US.